RICKETTSIAL STIMULATION OF ENDOTHELIAL PLATELET-ACTIVATING-FACTOR SYNTHESIS

被引:12
|
作者
WALKER, TS [1 ]
MELLOTT, GE [1 ]
机构
[1] BALL STATE UNIV, DEPT BIOL, MUNCIE, IN 47306 USA
关键词
D O I
10.1128/IAI.61.5.2024-2029.1993
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Endothelial cells (EC) synthesize platelet-activating factor (PAF) when activated by agents such as ATP or thrombin, and PAF production occurs as a consequence of endothelial phospholipase A activity. Because interactions between Rickettsia prowazekii and a variety of host cells result in the expression of phospholipase A activity, we assessed the relative abilities of uninfected and rickettsia-infected EC to synthesize PAF. Endothelial cells were infected with rickettsiae and examined at 24-h intervals for rickettsial multiplication, EC viability, and PAF synthesis. By 24 h postinfection, 80% of the EC were infected with an average of 10.6 rickettsiae per cell; by 72 h, the rickettsiae were too numerous to count and the numbers of viable EC began to decrease. Both rickettsia-infected and sham-treated EC synthesized PAF when stimulated with either thrombin or ATP, but rickettsia-infected EC synthesized about three times as much PAF in response to cell activation as did their uninfected counterparts. Additionally, unlike their uninfected counterparts, rickettsia-infected EC synthesized significant amounts of PAF in the absence of cell activation; rickettsia-infected EC synthesized as much PAF in the absence of activation as did uninfected EC in response to ATP. In each case, essentially all of the newly synthesized PAF remained with the cell pellet. Finally, EC incubated with high numbers of rickettsiae (1,000 rickettsiae per EC) for 30 min synthesized more PAF when activated with ATP than did their sham-treated activated counterparts.
引用
收藏
页码:2024 / 2029
页数:6
相关论文
共 50 条
  • [21] SYNTHESIS OF PHOSPHONO ANALOGS OF PHOSPHOLIPIDIC PLATELET-ACTIVATING-FACTOR
    CHUVILIN, AN
    TRUSOV, VG
    SEREBRENNIKOVA, GA
    BIOORGANICHESKAYA KHIMIYA, 1992, 18 (06): : 862 - 870
  • [22] EICOSANOIDS AND PLATELET-ACTIVATING-FACTOR
    FOEGH, ML
    XENOGRAFT 25, 1989, 880 : 171 - 179
  • [23] PLATELET-ACTIVATING-FACTOR AND THE KIDNEY
    SCHLONDORFF, D
    NEUWIRTH, R
    AMERICAN JOURNAL OF PHYSIOLOGY, 1986, 251 (01): : F1 - F11
  • [24] SYNTHESIS OF PLATELET-ACTIVATING-FACTOR BY NEONATAL LAMB LUNGS
    IBE, BO
    ISENBERG, WB
    RAJ, JU
    FASEB JOURNAL, 1991, 5 (05): : A1432 - A1432
  • [25] THE SYNTHESIS OF PLATELET-ACTIVATING-FACTOR IN BRAIN AND NEURAL CELLS
    GORACCI, G
    FRANCESCANGELI, E
    DREYFUS, H
    BOILA, A
    FREYSZ, L
    JOURNAL OF LIPID MEDIATORS AND CELL SIGNALLING, 1994, 10 (1-2): : 7 - 8
  • [26] PLATELET-ACTIVATING-FACTOR AND ASTHMA
    BARNES, PJ
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1991, 629 : 193 - 204
  • [27] PHARMACOLOGY OF PLATELET-ACTIVATING-FACTOR
    BRAQUET, P
    VARGAFTIG, BB
    TRANSPLANTATION PROCEEDINGS, 1986, 18 (05) : 10 - 19
  • [28] PLATELET-ACTIVATING-FACTOR AND THE CIRCULATION
    VANDONGEN, R
    JOURNAL OF HYPERTENSION, 1991, 9 (09) : 771 - 778
  • [29] PLATELET-ACTIVATING-FACTOR ANTAGONISTS
    KOLTAI, M
    BRAQUET, PG
    CLINICAL REVIEWS IN ALLERGY, 1994, 12 (04): : 361 - 380
  • [30] PLATELET-ACTIVATING-FACTOR AND ASTHMA
    MORLEY, J
    AGENTS AND ACTIONS, 1986, 19 (1-2): : 100 - 108